OUR PWS PRODUCT
DEVELOPMENT PATH
FDA Orphan Drug Development through Early Clinical Trials
YEAR 4
Product Development:
PWS Clinical (Approx 40 Patients anticipated, to be negotiated with FDA ODD

YEAR 4
Product Development:
PWS Clinical (Approx 40 Patients anticipated, to be negotiated with FDA ODD